Gregory Norden
CIK: 0001405104
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
Award(A)Direct1.4K shares- - Jun 5, 2026RPRX
Royalty Pharma plc
Award(A)Direct4.5K shares- - May 14, 2026RPRX
Royalty Pharma plc
Sale(S)Direct3K shares at avg. $53.00$161K - Mar 9, 2026ZTS
Zoetis Inc.
Gift(G)Direct1.2K shares- - Feb 19, 2026ZTS
Zoetis Inc.
Exercise(M)Direct1.6K shares- - Feb 19, 2026ZTS
Zoetis Inc.
Other(J)Direct406 shares at avg. $127.28$52K - Feb 18, 2026ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.9K shares- - Aug 11, 2025RPRX
Royalty Pharma plc
Sale(S)Direct33.5K shares at avg. $36.23$1.2M - Aug 8, 2025RPRX
Royalty Pharma plc
Conversion(C)Direct144.7K shares- - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
Award(A)DirectStock Option (Right to Buy)
10.5K shares- - May 13, 2025RPRX
Royalty Pharma plc
Award(A)Direct7.6K shares- - Feb 19, 2025ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.6K shares- - Feb 14, 2025ZTS
Zoetis Inc.
Gift(G)Direct1.8K shares- - Feb 8, 2025ZTS
Zoetis Inc.
Other(J)Direct308 shares at avg. $171.43$53K - Feb 8, 2025ZTS
Zoetis Inc.
Exercise(M)Direct1.2K shares- - Feb 6, 2025ZTS
Zoetis Inc.
Exercise(M)Direct1.2K shares- - Feb 6, 2025ZTS
Zoetis Inc.
Other(J)Direct310 shares at avg. $174.12$54K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award(A) | 1,371 | - | $0 | Direct |
| Jun 5, 2026 |  RPRX Royalty Pharma plc | Award(A) | 4,545 | - | $0 | Direct |
| May 14, 2026 | RPRX Royalty Pharma plc | Sale(S) | 3,045 | $53.00 | $161,385 | Direct |
| Mar 9, 2026 |  ZTS Zoetis Inc. | Gift(G) | 1,213 | - | $0 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Exercise(M) | 1,619 | - | $0 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Other(J) | 406 | $127.28 | $51,676 | Direct |
| Feb 18, 2026 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,936 | - | - | Direct |
| Aug 11, 2025 | RPRX Royalty Pharma plc | Sale(S) | 33,500 | $36.23 | $1,213,749 | Direct |
| Aug 8, 2025 | RPRX Royalty Pharma plc | Conversion(C) | 144,660 | - | - | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award(A) Stock Option (Right to Buy) | 10,520 | - | - | Direct |
| May 13, 2025 | RPRX Royalty Pharma plc | Award(A) | 7,614 | - | - | Direct |
| Feb 19, 2025 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,596 | - | - | Direct |
| Feb 14, 2025 | ZTS Zoetis Inc. | Gift(G) | 1,843 | - | - | Direct |
| Feb 8, 2025 | ZTS Zoetis Inc. | Other(J) | 308 | $171.43 | $52,800 | Direct |
| Feb 8, 2025 | ZTS Zoetis Inc. | Exercise(M) | 1,225 | - | - | Direct |
| Feb 6, 2025 | ZTS Zoetis Inc. | Exercise(M) | 1,236 | - | - | Direct |
| Feb 6, 2025 | ZTS Zoetis Inc. | Other(J) | 310 | $174.12 | $53,977 | Direct |
1-17 of 17 transactions
About Norden Gregory
Norden Gregory (SEC CIK 0001405104) files insider reports with the SEC as Director of Praxis Precision Medicines, Inc. (PRAX), Director of Royalty Pharma plc (RPRX) and Director of Zoetis Inc. (ZTS).
Signal8 holds 13 ownership filings by Norden Gregory, all Form 4s, filed between Feb 10, 2025 and Jun 12, 2026. Those filings report 17 transactions, from Feb 6, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Norden Gregory's filings is in NEW YORK, NY.
Recent filings by Norden Gregory
Other insiders filing for Praxis Precision Medicines, Inc. (PRAX)
- Souza Marcio, Chief Executive Officer
- DeSimone Jill, Director
- Arbuckle Stuart A, Director
- Chodakewitz Jeffrey, Director
- YOUNG WILLIAM D, Director
- Cudkowicz Merit Ester, Director